Clinical Trial Update: Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma [Phase 1]

View source ↗

Summary

Completed Phase I trial evaluating safety and early efficacy of combining sorafenib with gemcitabine and radiotherapy in locally advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED